EMEA-001625-PIP01-14-M03

Key facts

Active substance
Humanised anti-IL-6 receptor (IL-6R) monoclonal antibody
Therapeutic area
Neurology
Decision number
P/0220/2019
PIP number
EMEA-001625-PIP01-14-M03
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Treatment of neuromyelitis optica
Route(s) of administration
Subcutaneous use
Contact for public enquiries
Roche Registration GmbH

Tel. +41 616879411
E-mail: info.paediatrics@roche.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating